Peptide Tirzepatide Cartridge type Pen not included with Best Price and High Quality.
GMP ISO TDS 10 Inquiries
1428450-95-6
Cosmetics Grade
99%
Yangshan Port
SHUNZHICHENG
5mg 10mg 15mg/vial,10vials/box
2026-09-04
Semaglutide, tirzepatide, retatrutide, pharmaceutical peptides, cosmetic peptides, custom peptides,
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
N-[4-(2,4-Dihydroxyphenyl)-2-thiazolyl]-2-methylpropanamide
Other Name:Propanamide,N-[4-(2,4-dihydroxyphenyl)-2-thiazolyl]-2-methyl-;N-[4-(2,4-Dihydroxyphenyl)-2-thiazolyl]-2-methylpropanamide
CAS No.:1428450-95-6
Molecular Formula:C13H14N2O3S
InChIKeys:InChIKey=WIDNAJNXDPHROL-UHFFFAOYSA-N
Exact Mass:278.33
Categories:
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Semaglutide, tirzepatide, retatrutide, pharmaceutical peptides, cosmetic peptides, custom peptides,
-
Location:
Room 314A, Block A, Tianjin Youth Entrepreneurship Park, No. 85 Qingnian Road, Hongqiao District, Tianjin
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
20
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
101-200
-
Year of Establishment:
2026
-
-
Inquiry History10 Inquiries
Country Product Purchase Quantity Date Posted
France
Isobutylamido thiazolyl resorcinol CAS 1428450-95-6
10 KG Oct 15, 2024
United Kingdom
isobutylamido thiazolyl resorcinol powder CAS 1428450-95-6
10 MG Sep 21, 2024
Australia
Thiamidol - Isobutylamido Thiazolyl Resorcinol
100 G Dec 11, 2024
Colombia
Isobutylamido Thiazolyl Resorcinol
20 G Aug 24, 2024
India
thiamidol
1 KG Jan 26, 2026
United Kingdom
Thiamidol
1 KG Aug 11, 2025
United Kingdom
Thiamidol
1 KG Apr 18, 2025
Canada
Thiamidol 1428450-95-6
100 G Feb 25, 2026
Canada
Thiamidol 1428450-95-6 Isobutylamido Thiazolyl Resorcinol
100 G Feb 25, 2026
France
Isobutylamido thiazolyl riasorciinol CAS 199% High Purity White Powder Hot Sale Pharmace
10 KG Oct 15, 2024 Post an enquiry for this product